BEATING BREAST CANCER WITH SUCCESS CIC

Company limited by guarantee

Company Registration Number:
15329588 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2024

Period of accounts

Start date: 5 December 2023

End date: 31 December 2024

BEATING BREAST CANCER WITH SUCCESS CIC

Contents of the Financial Statements

for the Period Ended 31 December 2024

Directors report
Profit and loss
Balance sheet
Additional notes
Community Interest Report

BEATING BREAST CANCER WITH SUCCESS CIC

Directors' report period ended 31 December 2024

The directors present their report with the financial statements of the company for the period ended 31 December 2024

Directors

The director shown below has held office during the whole of the period from
5 December 2023 to 31 December 2024

Mrs S Pickles


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
30 September 2025

And signed on behalf of the board by:
Name: Mrs S Pickles
Status: Director

BEATING BREAST CANCER WITH SUCCESS CIC

Profit And Loss Account

for the Period Ended 31 December 2024

13 months to 31 December 2024


£
Turnover: 0
Cost of sales: 0
Gross profit(or loss): 0
Distribution costs: 0
Administrative expenses: 0
Other operating income: 0
Operating profit(or loss): 0
Interest receivable and similar income: 0
Interest payable and similar charges: 0
Profit(or loss) before tax: 0
Tax: 0
Profit(or loss) for the financial year: 0

BEATING BREAST CANCER WITH SUCCESS CIC

Balance sheet

As at 31 December 2024

Notes 13 months to 31 December 2024


£
Fixed assets
Intangible assets:   0
Tangible assets:   0
Investments:   0
Total fixed assets: 0
Current assets
Stocks:   0
Debtors:   0
Cash at bank and in hand: 0
Investments:   0
Total current assets: 0
Prepayments and accrued income: 0
Creditors: amounts falling due within one year:   0
Net current assets (liabilities): 0
Total assets less current liabilities: 0
Creditors: amounts falling due after more than one year:   0
Provision for liabilities: 0
Accruals and deferred income: 0
Total net assets (liabilities): 0
Members' funds
Profit and loss account: 0
Total members' funds: 0

The notes form part of these financial statements

BEATING BREAST CANCER WITH SUCCESS CIC

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 30 September 2025
and signed on behalf of the board by:

Name: Mrs S Pickles
Status: Director

The notes form part of these financial statements

BEATING BREAST CANCER WITH SUCCESS CIC

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

BEATING BREAST CANCER WITH SUCCESS CIC

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 2. Employees

    13 months to 31 December 2024
    Average number of employees during the period 1

COMMUNITY INTEREST ANNUAL REPORT

BEATING BREAST CANCER WITH SUCCESS CIC

Company Number: 15329588 (England and Wales)

Year Ending: 31 December 2024

Company activities and impact

During the financial year ending 31 December 2024, Beating Breast Cancer With Success CIC did not carry out any community projects as the organisation had not yet received funding. The CIC has, how-ever, continued to focus on laying the foundations for future activities, including building partner-ships, developing project plans, and seeking funding opportunities. The company remains committed to its social objectives of supporting and empowering individuals affected by breast cancer and intends to deliver projects and initiatives in the following financial year once funding is secured.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
29 September 2025

And signed on behalf of the board by:
Name: Mrs S Pickles
Status: Director